Peri-operative anaemia is a significant risk factor for morbidity and mortality. Anaemia during pregnancy is associated with adverse maternal and neonatal outcomes, and postpartum haemorrhage remains a leading cause of maternal mortality worldwide. Caesarean section is an operation incurring moderate risk of bleeding, and rates are rising globally. Recent international consensus guidelines recommend targeting a pre-operative haemoglobin > 130 g.l À1 for all patients having surgery with moderate-to-high risk of bleeding, regardless of sex. It is unclear how this recommendation translates to pregnant women, where anaemia is defined at a much lower haemoglobin level of < 110 g.l À1 . Long-standing definitions of anaemia during pregnancy are likely to be the result of flawed sampling of a so-called 'normal' but anaemic female population, given the high prevalence of iron deficiency and anaemia in healthy menstruating women. Contemporary data suggest that haemoglobin values in iron-replete pregnant women are higher than previously thought. The definition of anaemia has significant clinical implications, particularly for peri-operative management of women undergoing caesarean section. In addition, we should differentiate between lower reference values and optimal haemoglobin targets. The haemoglobin level associated with optimal obstetric and neonatal outcomes requires further investigation in pregnant women.
outcomes including postpartum infection and transfusion [7] , and severe anaemia is a risk factor for postpartum haemorrhage [4] , pre-eclampsia [8] and maternal mortality [9] . Anaemia is also associated with fatigue, limited exercise tolerance, dizziness, headaches and reduced cognitive performance [10, 11] , which may significantly impair a new mother's ability to care for an infant. Iron status correlates with maternal health-related quality of life variables such as general health, physical energy and mental health [12] .
Postpartum anaemia, defined as a haemoglobin concentration < 120 g.l
À1
, is associated with a higher burden of depressive symptoms [13] and adverse mother-infant interactions [14] . Maternal iron deficiency may also lead to adverse neurocognitive effects in the infant. Maternal ferritin levels correlate with neonatal ferritin levels, and iron-dependent neurogenesis is maximum during the third trimester and in early neonatal life [15, 16] . Fetal and neonatal iron deficiency may therefore result in deficits affecting memory, cognition and behaviour [17] .
Despite the recognised importance of anaemia peri-operatively, defining anaemia is challenging due to the high prevalence of undiagnosed anaemia in unselected patient populations [18] . We have reviewed the evidence behind current definitions of anaemia during pregnancy and the postpartum period, and existing guideline recommendations.
Methods
We performed a search for relevant literature including systematic reviews, meta-analyses, randomised controlled trials and cohort studies. Sources included PUBMED, MEDLINE, Google Scholar, using the following key words: anaemia; hemoglobin/haemoglobin; normal values; parturient; pregnant; and obstetric.
Results

Current definitions of anaemia in pregnancy
The most widely cited definition of anaemia is from the World Health Organization (WHO), which defines anaemia as a haemoglobin < 120 g.l À1 for women and < 110 g.l
À1
for pregnant women [19] . Severe anaemia during pregnancy is defined as haemoglobin < 70 g.l
. These definitions of anaemia were first published in 1968, and have not been revised. Most other definitions of anaemia by major guideline groups are similar to the WHO definition of anaemia ( Table 1) .
The WHO definitions of anaemia have been criticised because the data were obtained from a small number of unselected subjects, and used outdated methods of haemoglobin measurement [20, 21] . The WHO guidelines refer to four original scientific papers published during the 1950s and 1960s [22] [23] [24] [25] . Two of these did not include pregnant women [24, 25] .
The two studies that included pregnant women had small sample sizes of 82 [23] and 149 [22] , limiting the conclusions that can be made regarding reference ranges.
Both studies were designed to assess the impact of iron supplementation during pregnancy, and both suggested that iron supplementation increased haemoglobin concentration at term and postpartum, although these conclusions were limited by a lack of randomisation and blinding. The first of these studies measured haemoglobin Based on data from the Centers for Disease Control and Prevention (see Table 2 )
British Committee for Standards in Haematology, 2012 [61] First trimester: Hb < 110 g.l
Second trimester: Hb < 105 g.l
Post-partum: Hb < 100 g.l
'In view of the relative plasma expansion being particularly marked in the second trimester, it would seem reasonable to take 105 g.l À1 as the cut-off from 12 weeks' Australian Patient Blood Management Guideline, 2015 [42] 'There is no agreed normal range for haemoglobin values in pregnant women in Australia. . . In light of evidence that higher Hb levels may also be associated with adverse pregnancy outcomes, it would seem reasonable to assume that normal pregnancy haemoglobin levels lie between 103 and 146 g.l À1 '
Hb, haemoglobin; Hct, haematocrit.
values in healthy women divided into four groups (control, intramuscular iron supplementation, twice-daily oral iron supplementation and daily oral iron supplementation) [23] .
The mean haemoglobin values in each group at 2 months gestation were 125 g.l
, 131 g.l
and 114 g.l
, respectively, with data not reported for the fourth group.
At 6 months, the mean values were 114 g.l
, 118 g.l
and 118 g.l
, respectively, with data not reported for the fourth group. At term, the mean values were 109 g.l
, 127 g.l À1 and 124 g.l
, and 123 g.l
, respectively.
Measures of spread were not reported. There was a greater increase in haemoglobin mass in women receiving iron supplementation of 32%, compared with 15% in controls. The second of these studies measured haemoglobin values during the first trimester and at term, and women were divided into three groups (control, oral iron supplementation and intravenous (i.v.) iron supplementation) [22] . The mean haemoglobin during the first trimester was 121 g.l À1 before iron supplementation.
At term, haemoglobin values were 114 g.l
, 120 g.l
and 121 g.l À1 in each group, respectively.
Updated definition of anaemia
More recently, the use of a lower haemoglobin threshold to define anaemia in the female population has been , regardless of sex [26] . Similarly, Butcher et al.
recommend a haemoglobin threshold < 130 g.l À1 to trigger investigation and optimisation pre-operatively, regardless of sex, although they do not discuss the implications of redefining anaemia in the obstetric population [21] .
Evidence behind currently accepted reference ranges
Reference values to define anaemia during pregnancy should be based on haemoglobin values in healthy women without pre-existing haematinic deficiencies [18] .
There is a high prevalence of anaemia in otherwise healthy menstruating women of childbearing age. For example, almost 29% of non-pregnant women are anaemic globally [3] , and 45% of women of reproductive age have low or absent iron stores [17] . Cohort studies not screening for anaemia will therefore include iron-deficient women.
Based on a small sample of healthy women who underwent bone marrow aspirate during pregnancy, 29% of women had depleted iron stores early in pregnancy [23] . Similarly, 18% of pregnant women had deficient (<0 mg.kg À1 ) estimated total body iron stores using the serum ferritin and soluble transferrin receptor ratios [27] .
Normal pregnancy and childbirth are associated with increased iron requirements to facilitate haematopoiesis (570 mg), fetal iron stores (300 mg) and iron loss related to delivery blood loss (280 mg) [23] . Only 15-20% of women had adequate iron stores to meet the net iron requirements of pregnancy (~580 mg) [17, 28] . Without iron supplementation, 84% of healthy women have absent bone marrow iron stores at term pregnancy, and this persists for up to 6 months postpartum in 75% of women [23] . Any laboratory reference range that is calculated from an unselected sample of women will thus include a significant proportion of anaemic and/or iron-deficient women, and result in biased 'normal'
reference ranges.
The National Health and Nutrition Examination Survey However, the gestation at which haemoglobin was measured was not specified, and 18% of pregnant women had absent total body iron stores. This large cohort study suggests that the reference range for pregnant women is significantly higher than the haemoglobin threshold of 110 g.l À1 defined by the WHO and others. However, this may still underestimate 'normal' haemoglobin values during pregnancy, due to the inclusion of women with preexisting haematinic deficiencies, most commonly iron deficiency.
Although it is difficult to recruit women who are known to be iron replete before pregnancy, several cohort studies have measured haemoglobin trends in otherwise healthy women receiving iron supplementation ( , respectively [35, 36] .
Discussion
Redefining anaemia
There is no physiological reason why normal haemoglobin reference values should differ between men and nonpregnant women [37] . In fact, a lower haemoglobin value has elevated significance peri-operatively in women due to their lower total red cell mass, and lower total body iron stores compared with men; thus, the same total blood loss will generally have a proportionally greater effect in women [21] . Even mild anaemia is associated with adverse perioperative outcomes in women as well as men [38] . [18] . Haemoglobin values decrease during pregnancy due to 'dilutional anaemia' resulting from a proportionately greater rise in plasma volume than red blood cell mass [39] .
During the second trimester, haemoglobin values fall by approximately 5 g.l À1 [19] . However, this effect decreases towards term, and the degree of dilutional anaemia observed is attenuated with iron supplementation [34, 40] .
In the context of the known high prevalence of iron [41] . This is reflected in the publication of several recent obstetric-specific patient blood management guidelines [18, 42] . In Australia and New Zealand and the UK, guidelines recommend measurement of haemoglobin at 28 weeks gestation [43, 44] . This time-point represents an opportunity to investigate and intervene to correct anaemia before delivery.
Effective implementation of patient blood management pathways into routine obstetric care can reduce antenatal anaemia and reduce peripartum transfusion rates [45] . This is particularly important when caesarean section is planned due to the higher average blood loss compared with vaginal delivery [46] . Caesarean section results in calculated blood loss ranging from 440 ml [47] to 800 ml [46] -this equates to surgery with moderateto-high blood loss (> 500 ml) as defined by recent international consensus guidelines [26] . Caesarean delivery is associated with elevated risk of transfusion compared with non-operative vaginal delivery [48] , with transfusion rates of 2-4% [49] .
Although the physiological changes associated with pregnancy result in an increased red cell mass, iron stores may easily become depleted due to the elevated physiological demands of pregnancy and blood loss during delivery [17] . By the time anaemia develops, iron deficiency is severe, and total body iron stores are likely to be insufficient to meet the ongoing elevated demands of pregnancy and lactation. Worldwide, approximately 50% of anaemia in pregnancy is responsive to iron supplementation, and this may rise to 70% in high-income countries [3] . Multiparous women may particularly benefit from pre-operative haematinic optimisation. A higher parity is associated with reduced total body iron stores [27] , and a history of repeated caesarean section is associated with long-term anaemia [50] .
Iron supplementation is a low-cost and high-value intervention. A 2015 Cochrane review found that oral iron supplementation improved haemoglobin by 8.9 g.l À1 at term, compared with no supplementation [40] . This difference persisted at 6 weeks postpartum, with a mean difference of 7.6 g.l
À1
. Iron supplementation during pregnancy reduced the risk of maternal anaemia (haemoglobin < 110 g.l
) at term from 36% to 13%
(relative risk 0.30; 95%CI 0.19-0.46), and reduced maternal iron deficiency at term (relative risk 0.43; 95%CI 0.27-0.66) [40] . There was also a trend towards reduced rates of low birthweight and preterm birth, although the confidence intervals for these estimates were wide and were not statistically significant [40] .
Although oral iron is generally recommended as a firstline strategy for treating iron deficiency anaemia during pregnancy, its efficacy is limited by gastro-intestinal adverse effects, which may be particularly problematic in the pregnant population [51] . Adequate absorption is indicated by a rise in haemoglobin concentration of ≥ 10 g.l À1 after a 2-week trial of oral iron [51] . Intravenous iron is early in pregnancy have been associated with hypertension during pregnancy, low birthweight and preterm delivery [56] . A high maternal haemoglobin concentration of ≥ 140 g.l À1 at the end of second trimester has been associated with stillbirth [57] . The timing of haemoglobin measurement and outcome may be important, with one large cohort study suggesting that the nadir haemoglobin value has a U-shaped association with perinatal outcomes [58] .
It is unclear whether iron supplementation to achieve higher haemoglobin values is associated with harm in certain populations, and whether oral iron and i. [40] . Intravenous iron during pregnancy is associated with adverse reactions in 2.2-6.7%, although the definitions used are highly variable [59] . Concerns about over-correction of haemoglobin values were investigated in a retrospective study of pregnant women receiving iron infusions during pregnancy for both non-anaemic iron deficiency and iron deficiency anaemia [60] ; haemoglobin values measured at 3 and 6 weeks post-infusion did not demonstrate evidence of haemoconcentration.
Conclusion
Caesarean section has moderate-to-high blood-loss risk.
Peri-operative anaemia in women undergoing caesarean section represents an important global health issue. This is likely to be a more significant problem in low-and middleincome countries where caesarean section accounts for almost one-third of all operations performed, and there is a higher prevalence of anaemia compounded by reduced access to interventions such as iron infusions and blood transfusions.
Future research should focus on prospectively defining normal haemoglobin trends during pregnancy using a cohort of non-iron-deficient, non-anaemic women early in pregnancy. In addition to defining true normal reference ranges, the optimal haemoglobin values during pregnancy to reduce maternal and neonatal morbidity and mortality are unknown. This is important in order to guide optimal treatment end-points when implementing patient blood management strategies in the obstetric population. Future studies investigating haemoglobin optimisation during pregnancy should investigate the impact of both anaemia optimisation and the impact of treating non-anaemic iron deficiency on patient-centred outcomes such as quality of life in addition to maternal and neonatal morbidity outcomes. Finally, concerns about potential perinatal harm related to higher haemoglobin values during pregnancy require further investigation.
